Introduction
============

Respiratory illness due to the influenza virus and other respiratory pathogens is a major cause of morbidity and mortality worldwide. According to the World Health Organization (WHO), these annual epidemics result in 3--5 million cases of severe illness and 250--500 thousand deaths worldwide \[[@B1]\]. In particular, the proportion of acute respiratory illness (ARI) cases due to influenza becomes higher in the winter season with increased morbidity and mortality \[[@B2][@B3]\].

Patients with influenza are known to present with influenza-like illness (ILI), which includes fever and respiratory symptoms. However, some patients show atypical manifestations. Although many hospitalizations are due to pneumonia (viral and bacterial), influenza is also complicated by acute exacerbation of cardiovascular and pulmonary diseases. Moreover, neuromuscular complications, such as encephalopathy, transverse myelitis, and aseptic meningitis, have been reported in influenza patients \[[@B4][@B5]\].

Influenza surveillance systems are essential components of public health systems. WHO recommends the surveillance of ILI and severe acute respiratory infection (SARI) to respond effectively to both seasonal influenza epidemics and pandemics \[[@B6]\]. Some studies, however, have reported that laboratory-confirmed influenza (LCI) with complications is not completely compatible with ILI criteria \[[@B4][@B7][@B8]\]. Although most of the current surveillance systems are based on ILI, some patients do not present with typical ILI, especially elderly patients \[[@B9]\]. In this aspect, the usual criteria of ILI and SARI are limited in their ability to predict the risk of influenza-related complications or hospitalization.

In South Korea, the Transgovernmental Enterprise for Pandemic Influenza in Korea (TEPIK) has existed since 2011. TEPIK developed the "Hospital-based Influenza Morbidity and Mortality" (HIMM) surveillance system, which consists of an integrated clinical and laboratory surveillance system. Currently, 10 university hospitals use this system on a nationwide scale. This system monitors not only influenza activity but also the severity of influenza, such as hospitalizations, complications, and mortality. It is important to monitor the severity of influenza and collect viral isolates in order to analyze the virulence of circulating strains. Additionally, this system can detect and track the course of influenza cases with typical ILI as well as non-ILI.

In this study, therefore, we aimed to identify risk factors for SARI and pneumonia among adult patients with ARI during the 2011-2014 influenza seasons using HIMM surveillance data in Korea.

Materials and Methods
=====================

1. Study design {#sec1}
---------------

A prospective observational design was used. The study period extended through the 2011-2012, 2012-2013, and 2013-2014 influenza seasons. Influenza season was defined from October 1 to the first week of May in accordance with the recommendations of Centers for Disease Control and Prevention (CDC) \[[@B10]\]. Analyses were performed according to the week of the year, with Week 1 defined as the week (from Monday through Sunday) in which January 1 fell. The study conducted at the 10 tertiary university hospitals, including Guro Hospital of Korea University College of Medicine, Ansan Hospital of Korea University College of Medicine, St. Vincent\'s Hospital of College of Medicine, the Catholic University of Korea, Hospital of Kyungpook National University School of Medicine, Hospital of Pusan National University School of Medicine, Hospital of Chonnam National University School of Medicine, Hospital of Chungbuk National University School of Medicine, and Kangnam Sacred Heart Hospital, Hallym University School of Medicine. Participating sites prospectively enrolled the data of adult patients (\>18 years of age) who visited the emergency room with an ARI.

2. Definitions {#sec2}
--------------

ARI was defined as follows: (1) one or more respiratory symptom (cough, sore throat, shortness of breath) (2) considered by the doctor to be due to infection. ILI, according to the Centers for Disease Control and Prevention (CDC), was defined as a history of fever or sudden onset of fever (\>37.8°C, within 7 days) and a cough and/or sore throat without a known acute respiratory infection other than influenza. The following SARI case definition was used: (1) history of fever or sudden onset of fever (\>37.8°C, within 7 days), (2) one or more respiratory symptom (cough, sore throat, rhinorrhea), (3) shortness of breath or difficulty breathing, and (4) admission \[[@B11]\]. However, the HIMM system uses "modified SARI," which is defined as either (A) classical SARI by WHO or (B) non-ILI SARI with laboratory-confirmed influenza-related admission. A rapid antigen test (SD Bioline Rapid Influenza Test, Standard Diagnostics, Inc., Yongin, Korea) and a 15 respiratory virus (RV) polymerase chain reaction (PCR) test (Seeplex^®^ RV15 ACE Detection, Seegene INc., Seoul, Korea) using nasopharyngeal swabs were performed for the diagnosis of LCI. This study was approved by the Korea University Guro Hospital Institutional Review Board \[KUGH11088-001\].

3. Study measures {#sec3}
-----------------

The following information was recorded: age, sex, episodes of pneumonia and other complications, medical history, *etc*. In addition, we classified the admitted patients into seven different groups based on their reason for admission regardless of whether they were diagnosed as classical SARI or modified SARI.

Group A: Lower respiratory infection at image (pneumonia)B: Other respiratory infection complication (acute epiglottitis, acute otitis media, laryngitis, vestibular neuritis, bronchiolitis)C: Encephalopathy, transient ischemic attack (TIA), spontaneous subdural hematoma (SDH)D: Acute myocardial infarction (AMI), myocarditis, pericardial effusionE: Severe dehydration (poor oral intake plus skin turgor plus acute kidney injury)F: Aggravation of chronic disease (asthma, chronic obstructive pulmonary disease (COPD), chronic liver disease, chronic kidney disease (CKD), cardiovascular disease)G: Other severe subjective symptom (myalgia, poor oral intake, threatened abortion)

4. Statistical analysis {#sec4}
-----------------------

Risk factors for SARI and pneumonia were analyzed. Continuous variables were compared by the Student's independent *t*-test, while categorical variables were compared using the chi-square test. Multivariate analyses were performed using stepwise logistic regression analysis for risk factors of pneumonia and SARI, and the risk ratios with a 95% confidence interval (CI) were calculated. Factors found to be significant in the univariate logistic regression analysis were included as independent variables in the multivariate logistic regression. In addition, we calculated the odd ratios (ORs) for SARI and pneumonia between the cases who had multiple risk factors and those who did not have any risk factors. In this analysis, the risk factors were counted equally regardless of type. All analyses were performed using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA).

Results
=======

A total of 6,275 cases were registered to the study in the 2011-2014 influenza seasons. Eight patients who did not have ARI and 816 patients who had ARI but had unknown past medical histories were excluded ([Fig. 1](#F1){ref-type="fig"}). As a result, 5,459 cases were eligible for this analysis. Among 5,459 cases, 2,887 cases (52.9%) were identified that they had LCI. Other viruses were summarized in [Supplementary Table 1](#S1){ref-type="supplementary-material"}.
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1. Characteristics of population {#sec1___1}
--------------------------------

The baseline characteristics of enrolled cases are summarized in [Table 1](#T1){ref-type="table"}. The proportion of females was higher than that of males (42.9%). The mean age of patients with ARI was 48.8 years. Although most patients with ARI were under 65 (72.8%), more than half (52%) had comorbidities. Among the 5,459 enrolled cases, 750 cases (13.7%) belonged to the modified SARI group, while 4,709 cases (86.3%) belonged to the non-SARI group (control). Among the 750 patients with modified SARI, 682 (91%) patients had ILI, and 68 patients did not meet the ILI definition ([Fig. 1](#F1){ref-type="fig"}). Specifically, in Group A, pneumonia was most common (317, 42.3%), followed by Group E (severe dehydration, 122, 16.3%), Group F (aggravation of chronic disease, 123, 16.4%), Group B (other respiratory infection complication, 31, 4.1%), Group C (brain complication, 11, 1.5%), and Group D (cardiovascular complications, 8, 1.1%).

###### Baseline characteristics of enrolled adult cases with acute respiratory illness

![](ic-48-294-i001)

  Baseline demographic and clinical characteristics (total no. = 5,459)   Data (n, %)
  ----------------------------------------------------------------------- --------------
  Male sex - no. (%)                                                      2356 (42.9%)
  Age (year) - mean (range)                                               48.8 (18-99)
  Age (group) - no. (%)                                                   3976 (72.8)
   18-64 years                                                            1483 (27.2)
   65-99 years                                                            
  Comorbidity - no. (%)                                                   2841 (52)
   Hypertension                                                           1197 (22.9)
   Diabetes mellitus                                                      670 (12.3)
   Solid cancer                                                           356 (6.5)
   Chronic heart disease                                                  322 (5.9)
   Cerebrovascular disease                                                256 (4.7)
   Asthma                                                                 163 (3)
   Chronic kidney disease                                                 156 (2.9)
   Chronic liver disease                                                  130 (2.4)
   Autoimmune disease                                                     113 (2.1)
   Chronic obstructive pulmonary disease                                  
   Neuromuscular disease                                                  80 (1.5)
   Hematologic malignancy                                                 39 (\<0.1)
   Solid organ transplantation                                            11 (\<0.1)
   Bone marrow transplantation                                            1 (\<0.1)
   HIV/AIDS                                                               17 (\<0.1)

HIV, human immunodeficiency virus; AIDS, acquired immune deficiency syndrome

2. Risk factors of modified SARI and pneumonia {#sec2___1}
----------------------------------------------

When we analyzed the risk factors for modified SARI, the univariate analysis revealed the following factors were statistically significant: influenza vaccine, pneumococcal vaccine, old age (over 65 years), diabetes mellitus (DM), chronic heart diseases (CHD), cerebrovascular disease (CVD), neuromuscular disease, COPD, asthma, CKD, chronic liver disease, solid cancer, immunocompromised diseases, and autoimmune diseases ([Table 2](#T2){ref-type="table"}). The multivariate analyses revealed the following factors were associated with an increased risk for modified SARI: old age (over 65 years) (OR 2.69, 95% CI 2.2-3.32), CHD (OR 2.24, 95% CI 1.68-2.98), CVD (OR 1.49, 95% CI 1.05-2.10), COPD (OR 2.34, 95% CI 1.48-3.69), asthma (OR 2.33, 95% CI 1.62-3.36), CKD (OR 2.62, 95% CI 1.73-3.99), chronic liver disease (CLD) (OR 1.71, 95% CI 1.04-2.81), and autoimmune diseases (OR 2.53, 1.57-4.08).

###### Analysis of risk factors for severe acute respiratory infection among adult cases with acute respiratory illness

![](ic-48-294-i002)

                            Control group (n = 4709)   Modified SARI (n = 750)   Univariate analysis   Multivariate analysis
  ------------------------- -------------------------- ------------------------- --------------------- -----------------------
  Age, mean years (SD)      46.7 (SD 19.2)             61.6 (SD 18.9)            \<0.001               
  Male sex - no. (%)        2,015 (42.8%)              326 (43.5%)               0.728                 
  Influenza vaccine^a^      1,365                      305                       \<0.001               0.84 (0.68-1.03)
  Pneumococcal vaccine^b^   564                        92                        \<0.001               
  Age \< 65                 3291                       270                       \<0.001               
  Age ≥ 65                  743                        164                       \<0.001               
  DM                        506 (10.7%)                164 (3.5%)                \<0.001               0.94 (0.73--1.20)
  Chronic heart disease     189 (4%)                   103 (13.7%)               \<0.001               2.24 (1.68--2.98)
  CVD                       17,177 (3.8%)              79 (10.5%)                \<0.001               1.49 (1.05--2.10)
  Neuromuscular             56 (1.2%)                  24 (3.2%)                 \<0.001               1.2 (0.67--2.13)
  COPD                      48 (1%)                    45 (6%)                   \<0.001               2.34 (1.48--3.69)
  Asthma                    94 (2%)                    69 (9.2%)                 \<0.001               2.33 (1.62--3.36)
  CKD                       95 (2%)                    61 (8.1%)                 \<0.001               2.62 (1.73--3.98)
  CLD                       101 (2.1%)                 29 (3.9%)                 \<0.004               1.71 (1.04--2.81)
  Solid cancer              276 (5.9%)                 80 (10.7%)                \<0.001               1.17 (0.86--1.59)
  Immunocompromised         51 (1.1%)                  17 (2.3%)                 0.007                 1.71 (0.92--3.20)
  -Hematologic malignancy   30                         9                                               
  -Solid organ transplant   8                          3                                               
  -BMT                      1                          0                                               
  -HIV/AIDS                 13                         4                                               
  Autoimmune disease        79 (1.7%)                  34 (4.5%)                 \<0.001               2.53 (1.57--4.09)

SARI, severe acute respiratory infection; CI, confidence interval; SD, standard deviation; DM, diabetes mellitus; CVD, cerebrovascular disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; CLD, chronic liver disease; BMT, bone marrow transplantation; HIV, human immunodeficiency virus; AIDS, acquired immune deficiency syndrome.

^a^Influenza vaccination record was not available in 215 patients.

^b^Pneumococcal vaccination record was not available in 1,598 patients.

With respect to pneumonia development, 317 cases were accompanied by pneumonia, and 5,142 cases were not. When we analyzed the risk factors for pneumonia, the univariate analysis revealed the following factors were statistically significant: influenza vaccine, pneumococcal vaccine, old age (over 65 years), DM, CHD, CVD, neuromuscular disease, COPD, asthma, CKD, CLD, solid cancer, immunocompromised diseases, and autoimmune diseases ([Table 3](#T3){ref-type="table"}). The multivariate analyses revealed the following factors were independent risk factors for pneumonia development: influenza vaccine (OR 0.74, 95% CI 0.54-1.0), old age (≥65 years) (OR 5.71, 95% CI 4.10-7.94), CHD (OR 1.54, 95% CI 1.07-2.22), COPD (OR 2.34, 95% CI 1.48-3.69), asthma (OR 2.33, 95% CI 1.62-3.36), CKD (OR 2.62, 95% CI 1.73-3.99), immunocompromised conditions (OR 3.12, 95% CI 1.47-6.62), and autoimmune diseases (OR 3.35, 95% CI 1.79-6.27) ([Table 3](#T3){ref-type="table"}).

###### Analysis of risk factors for pneumonia development among adult cases with acute respiratory illness
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                              Non-pneumonia (n = 5,142)   Pneumonia (n = 317)   Univariate analysis   Multivariate analysis
  --------------------------- --------------------------- --------------------- --------------------- -----------------------
  Age (year) - mean           47.5 (SD 19.4)              68.5 (SD 15.8)        \<0.001               
  Male sex - no. (%)          2168 (42.2%)                173 (54.6%)           \<0.001               
  Influenza vaccine ^a^       1530                        140                   \<0.001               0.74 (0.54-1.0)
  Pneumococcal vaccine ^b^    274                         52                    \<0.001               1.29 (0.87-1.92)
  Age \< 65                   3496                        65                    \<0.001               
  Age ≥ 65                    820                         87                    \<0.001               
  DM                          577 (11.2%)                 93 (29.3%)            \<0.001               1.15 (0.84-1.59)
  Chronic heart disease       255 (6.1%)                  67 (21.1%)            \<0.001               1.54 (1.07-2.22)
  CVD                         211 (4.1%)                  45 (14.2%)            \<0.001               1.37 (0.89-2.12)
  Neuromuscular               63 (1.2%)                   17 (5.4%)             \<0.001               1.81 (0.94-3.5)
  COPD                        67 (1.3%)                   26 (8.2%)             \<0.001               2.01 (1.18-3.44)
  Asthma                      130 (2.5%)                  33 (10.4%)            \<0.001               2.13 (1.35-3.35)
  CKD                         116 (2.3%)                  40 (12.6%)            \<0.001               3.81 (2.36-6.16)
  CLD                         115 (2.3%)                  15 (4.7%)             0.006                 1.86 (0.93-3.5)
  Solid cancer                319 (6.2%)                  37 (11.7%)            \<0.001               1.10 (0.71-1.71)
  Immunocompromised           56 (1.1%)                   12 (3.8%)             \<0.001               3.12 (1.47-6.62)
   -Hematologic malignancy    33                          6                                           
   -Solid organ transplant,   9                           2                                           
   -BMT                       1                           0                                           
   -HIV/AIDS                  14                          4                                           
  Autoimmune disease          95 (1.9%)                   18 (5.7%)             \<.001                3.35 (1.79-6.27)

CI, confidence interval; SD, standard deviation; DM, diabetes mellitus; CVD, cerebrovascular disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; CLD, chronic liver disease; BMT, bone marrow transplantation; HIV, human immunodeficiency virus; AIDS, acquired immune deficiency syndrome

^a^Influenza vaccination record was not available in 215 patients.

^b^Pneumococcal vaccination record was not available in 1,598 patients.

Furthermore, the risk of modified SARI and pneumonia was significantly increased by the number of concurrent chronic medical conditions. The risk ratio of modified SARI increased about 9.5 times as the number of SARI risk factors increased from zero to four. Moreover, the risk ratio of pneumonia increased about 16 times as the number of pneumonia risk factors increased from zero to four ([Fig. 2](#F2){ref-type="fig"}).

![Risk of SARI and pneumonia following acute respiratory illness in adult cases with multiple risk factors\
(A) The risk ratio of modified SARI increases about 9.5 times as the number of SARI risk factors increases from zero to four. (B) The risk ratio of pneumonia increases about 16 times as the number of pneumonia risk factors increases from zero to four.\
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Discussion
==========

In this study, we found several independent risk factors related to hospitalization among adult patients with ARI at medical emergency departments (EDs) in Korea. In addition, we identified several independent risk factors for pneumonia development after ARI among adult patients who visited EDs in influenza season. The present study showed that old age and CKD were most strongly associated with modified SARI, while old age, immunocompromised conditions, and autoimmune diseases were strongly related to pneumonia. This study would be valuable in several aspects. First of all, this multi-centered study was conducted prospectively. HIMM has been operated for more than three influenza seasons; the data was collected by well-trained research nurses, and confirmed by investigational physicians in each hospital. Secondly, because non-ILI SARI cases were included, this study might be useful to understand the spectrum of severe influenza comprehensively.

Going one step forward, the risk of modified SARI and pneumonia was significantly increased by the number of concurrent chronic medical conditions ([Fig. 2](#F2){ref-type="fig"}). The Government of South Korea, however, has a national influenza immunization and pneumococcal vaccination program that just targets the elderly (aged over 65 years). Thus, we need to evaluate the cost-effectiveness of influenza and pneumococcal vaccination for young adults with multiple comorbidities.

Respiratory complications after influenza infection are known to be more common than non-respiratory complications \[[@B5]\]. However in etiological studies of encephalitis, Influenza A and/or B have been identified in up to 8.5% of adult patients \[[@B12]\] and in up to 10% of pediatric cases \[[@B13]\]. In this study, 11 patients (1.7%) were identified as having LCI with encephalopathy, TIA, or spontaneous SDH among the total of 649 LCI patients. The proportion of patients manifesting central nervous system (CNS) complications is about 1.1% among ARI cases in flu season. In the case of cardiovascular complications, Guan et al. \[[@B14]\] reported a 7.5 OR (95% CI 1.3-43.0) in Influenza A and a 27.3 OR (95% CI 6.6-113.8) in Influenza B. Cardiac complications, such as myocarditis, are well recognized, but the role of influenza as a trigger of acute myocardial infarction is less clear. In this study, we found that 11 (1.7%) patients were identified as having LCI with cardiac complications (AMI, myocarditis, or pericardial effusion) among the total of 649 LCI patients. In addition, among 12 patients who were classified as having aggravation of heart failure without myocarditis or myocardial infarction, 11 patients had influenza infections identified by laboratory tests. Because we classified aggravation of heart failure (11 patients, 1.7%) as Group F (aggravation of chronic diseases), if taken together, the impact of influenza on the cardiovascular system might be much greater. During influenza season, influenza should be considered a triggering factor for cardiovascular complications, cerebrovascular events, and other CNS complications.

This study has several limitations to be considered. First, a large proportion of patients had severe underlying diseases, because these centers are tertiary hospitals. Second limitation is that hospitalization is a complex outcome resulting from multiple components: the physician's decision as well as the patient's decision to seek medical attention, occupation, and economic problems. Depending on the circumstances, some of the extraneous factors may play an important role in the outcome (hospitalization) and thus make the interpretation of our results challenging.

In conclusion, old age and chronic medical conditions were independent risk factors for SARI and pneumonia, and the risk was significantly increased by the number of underlying comorbidities in Korea.
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###### Supplementary Table 1

The result of respiratory virus PCR test
